Escalon Medical Receivables

The latest receivables for ESMC is $1.4B as of March 2026. That compares with $2.3B in the prior-year period — down 37.2% year over year. Investors often review this figure alongside Escalon Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, ESMC's receivables moved from $2.3B to $1.4B — a 37.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Escalon Medical's operating scale or balance-sheet position.

A receivables figure of $1.4B for ESMC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ESMC's receivables ($1.4B), review year-over-year change from $2.3B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.